{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Sutro Biopharma, Inc."},"Symbol":{"label":"Symbol","value":"STRO"},"Address":{"label":"Address","value":"111 OYSTER POINT BOULEVARD,SUITE 150, SOUTH SAN FRANCISCO, California, 94080, United States"},"Phone":{"label":"Phone","value":"+1 650 881-6500"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers."},"CompanyUrl":{"label":"Company Url","value":"https://www.sutrobio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Anne E Borgman","title":"Chief Medical Officer"},{"name":"Craig Berman","title":"Vice President-Clinical Development"},{"name":"Hans-Peter Gerber","title":"Chief Scientific Officer"},{"name":"Henry Heinsohn","title":"Vice President-Technology & Innovation"},{"name":"Jane Chung","title":"President & Chief Operating Officer"},{"name":"Steve Michel","title":"Vice President-Information Technology"},{"name":"William J. Newell","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}